The comparison between GLP-1RA and SGLT-2 inhibitors shows no difference in their risk for nonfatal MI (RR = 1.04, 95% CI 0.921.19)
The drugs are also effective in promoting weight loss if taken according to their treatment plan, which means patients should take the drugs continuously for at least 12 weeks
As the only injection to support weight loss in three ways
The field is evolving rapidly, but retatrutide currently holds the weight loss efficacy record among investigational compounds
A survey studying safety, efficacy, patient compliance and cost-effectiveness of transdermal, oral and intramuscular pain medication showed that all the patients experienced pain on injecting the drug
To identify the mechanism behind the analgesic effects of GLP-1 analogs and exendin 939, we utilized a cell line lacking GLP-1R to transfect the rat TRPV1 plasmid